Lidocaine patches could be an alternative pain solution. Lidocaine patches may be effective for patients who are in pain but are looking to avoid drugs that could be addictive. Whenever a patient ...

The results of this exploratory study suggest that Lidoderm can alleviate the pain associated with OA of the knee. "The results of this exploratory study suggest that Lidoderm can alleviate the pain ...

The US District Court for the Northern District of California certified classes of direct purchasers and end-payers in a pay-for-delay multidistrict litigation involving Lidoderm. In re Lidoderm ...

A preclinical study commissioned by Alliqua, Inc. (OTCQB: ALQA) ("Alliqua" or "the Company") concluded that the Company's investigational lidocaine transdermal patch compares favorably to the Lidoderm ...

CHADDS FORD, Pa., March 31, 2005 – Today at the 24th Annual Scientific Meeting of the American Pain Society, Endo Pharmaceuticals Inc. released new clinical trial data which found patients receiving ...

PHILADELPHIA (Legal Newsline) – Endo Health Solutions Inc. and its subsidiary, Endo Pharmaceuticals, have agreed to a $171.9 million settlement with the federal government to resolve off-label ...

SAN FRANCISCO (CN) - A federal judge on Thursday finalized two class action settlements worth $270 million, ending four years of litigation over an alleged antitrust conspiracy to keep a generic form ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (ANDA) approval from ...

Amneal has received Food and Drug Administration approval for its lidocaine patch 5%. The product is a generic of Lidoderm Patch 5%. “We are pleased to announce the approval for the Lidocaine Patch, 5 ...

Aveva Drug Delivery Systems has received permission from the Food and Drug Administration for its generic lidocaine 1.8% patch, a non-opioid topical treatment for post-herpetic neuralgia. The generic ...

The pharmacokinetics, safety, and tolerability of four topical lidocaine patches 5% continuously applied for 72 hours and changed every 12 or 24 hours were examined. In this randomized, prospective, ...